A Randomized, Double-Blind, Placebo-Controlled Phase I Study To Determine The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
At a glance
- Drugs PBL 1427 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 10 Jun 2017 Biomarkers information updated
- 15 May 2013 Planned end date changed from 1 Feb 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.